LP
SOPH icon

Longaeva Partners’s SOPHiA GENETICS SOPH Stock Holding History

Longaeva Partners’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
+50,000
New +$254K 0.01% 333

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Longaeva Partners's SOPH Position: Q2 2026 in Review

Longaeva Partners opened a new position in SOPHiA GENETICS (SOPH) in Q2 2026: 50,000 shares worth $289K. The stake represents 0.01% of the portfolio and ranks #333 among its holdings.

72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Longaeva Partners held 50,000 shares of SOPHiA GENETICS worth $289K as of Q2 2026.
  • SOPHiA GENETICS was a new Longaeva Partners position in Q2 2026.
  • SOPHiA GENETICS made up 0.01% of Longaeva Partners's portfolio in Q2 2026, its #333 holding.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.